Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3533 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3287 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-12 | 2025-08-22 | 260159 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260162 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260669 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260678 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-10 | 260687 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-19 | 2025-08-22 | 260690 |
| APO-LEVOTHYROXINE | 112MCG | TABLET | Resolved | 2025-06-19 | 2025-11-07 | 260693 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-20 | 2025-10-16 | 260817 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-31 | 260820 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-10 | 260823 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-07-03 | 2025-10-10 | 261632 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-07-03 | 2025-10-24 | 261641 |
| APO-LEVOTHYROXINE | 75MCG | TABLET | Resolved | 2025-07-10 | 2025-10-16 | 262412 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-07-10 | 2025-11-14 | 262425 |
| APO-LEVOTHYROXINE | 75MCG | TABLET | Resolved | 2025-07-10 | 2025-10-10 | 262429 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-08-14 | 2025-11-07 | 265284 |
| APO-LINEZOLID | 600MG | TABLET | Resolved | 2018-03-05 | 2019-11-04 | 41855 |
| APO-LINEZOLID | 600MG | TABLET TABLET | Resolved | 2022-05-13 | 2022-09-30 | 160607 |
| APO-LINEZOLID | 600MG | TABLET TABLET | Resolved | 2023-10-27 | 2023-11-10 | 208379 |
| APO-LISINOPRIL | 5MG | TABLET | Actual shortage | 2023-07-13 | 2025-01-30 | 198528 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |